[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Lateral Flow Assay Market Forecast to 2030 - Regional Analysis - by Product Type (Kits & Reagents and Lateral Flow Readers), Technique (Sandwich Assay, Competitive Assays, and Multiplex Detection Assay), Test Type (Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, and Drug Development & Quality Testing), and End User (Hospitals and Clinics, Diagnostics Laboratories, Homecare, Veterinary Clinics, Pharmaceutical & Biotechnology Companies, and Others)

May 2024 | 145 pages | ID: E74DEF2F1394EN
The Insight Partners

US$ 3,550.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Europe lateral flow assay market was valued at US$ 2,558.72 million in 2022 and is expected to reach US$ 4,820.39 million by 2030; it is estimated to register a CAGR of 8.2% from 2022 to 2030.
Rising Popularity of Point-of-Care Testing Drives Europe Lateral Flow Assay Market
Lateral flow assay-based point-of-care (POC) diagnostic tools are rapid, easy-to-use, and low-cost paper-based procedures, which are specifically perceived to be beneficial in resource-limited settings and industrialized countries. These tests are increasingly replacing prolonged, conventional laboratory methods. No training and complex infrastructures are required to run POC diagnostic tests. Thus, these tests cost less than conventional laboratory diagnostic techniques. POC testing tools are expected to be a crucial revenue pocket in the lateral flow assay market because of their prominent role in combating the burgeoning disease burden. Many companies are engaged in developing innovative lateral flow assay-based POC devices for infectious disease diagnosis, drugs-of-abuse screening, pregnancy (using hCG levels) and ovulation confirmation, and blood protein marker measurement.
The rising popularity of POC testing and ongoing developments in lateral flow assay-based POC testing fuel the growth of the lateral flow assay market.
Europe Lateral Flow Assay Market Overview
Germany, the UK, France, Italy, and Spain are the major countries in Europe, including the rest of European countries. Germany held the largest market for lateral flow assay in the region in 2022. The growth of the lateral flow assay market in the region is attributed to factors such as the increasing geriatric population, the growing rate of accidents, and population growth in the region. Other major drivers include technological innovations and increasing demand for technologies in Germany, France, and the UK.
The pharmaceutical industry in Germany holds the global fourth largest position with small and mid-sized companies. According to the International Trade Administration (ITA), the pharmaceutical market in Germany accounted for US$ 62.5 billion in 2019 and will expect to increase in future. The country is likely to remain one of the most attractive destinations for the global pharmaceutical industry in the coming years in terms of manufacturing and supply. According to the ECDC's Annual epidemiological report, chlamydia infection, campylobacteriosis, salmonellosis, gonorrhea, and tuberculosis were the most frequently reported notifiable infectious diseases in the EU and The European Economic Area (EEA).
Europe Lateral Flow Assay Market Revenue and Forecast to 2030 (US$ Million)
Europe Lateral Flow Assay Market Segmentation
The Europe lateral flow assay market is categorized into product type, technique, test type, application, end user, and country.
Based on product type, the Europe lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held a larger Europe lateral flow assay market share in 2022.
In terms of technique, the Europe lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held the largest Europe lateral flow assay market share in 2022.
By test type, the Europe lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held a larger Europe lateral flow assay market share in 2022.
Based on application, the Europe lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held the largest Europe lateral flow assay market share in 2022.
By end user, the Europe lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held the largest Europe lateral flow assay market share in 2022.
By country, the Europe lateral flow assay market is segmented into the UK, Germany, France, Spain, Italy, Benelux, and the Rest of Europe. Germany dominated the Europe lateral flow assay market share in 2022.
F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe lateral flow assay market.
1. INTRODUCTION

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. EXECUTIVE SUMMARY

2.1 Key Insights

3. RESEARCH METHODOLOGY

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. EUROPE LATERAL FLOW ASSAY MARKET - KEY INDUSTRY DYNAMICS

4.1 Europe Lateral Flow Assay Market - Key Industry Dynamics
4.2 Market Drivers
  4.2.1 Increasing Use of Home-Based Assay Kits
  4.2.2 Rising Popularity of Point-of-Care Testing
4.3 Market Restraints
  4.3.1 Inconsistent Assay Results Due to Procedural Limitations
4.4 Market Opportunities
  4.4.1 Evolving Applications of Lateral Flow Assays
4.5 Future Trends
  4.5.1 Smartphone Usage and AI Integration in Lateral Flow Immunoassay
4.6 Impact analysis

5. LATERAL FLOW ASSAY MARKET - EUROPE MARKET ANALYSIS

5.1 Europe Lateral Flow Assay Market Revenue (US$ Mn), 2020 - 2030

6. EUROPE LATERAL FLOW ASSAY MARKET ANALYSIS - PRODUCT TYPE

6.1 Kits & Reagents
  6.1.1 Overview
  6.1.2 Kits & Reagents: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Lateral Flow Readers
  6.2.1 Overview
  6.2.2 Lateral Flow Readers: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

7. EUROPE LATERAL FLOW ASSAY MARKET ANALYSIS - TECHNIQUE

7.1 Sandwich Assay
  7.1.1 Overview
  7.1.2 Sandwich Assay: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Competitive Assays
  7.2.1 Overview
  7.2.2 Competitive Assays: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Multiplex Detection Assay
  7.3.1 Overview
  7.3.2 Multiplex Detection Assay: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

8. EUROPE LATERAL FLOW ASSAY MARKET ANALYSIS - TEST TYPE

8.1 Lateral Flow Immunoassay
  8.1.1 Overview
  8.1.2 Lateral Flow Immunoassay: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
8.2 Nucleic Acid Lateral Flow Assay
  8.2.1 Overview
  8.2.2 Nucleic Acid Lateral Flow Assay: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

9. EUROPE LATERAL FLOW ASSAY MARKET ANALYSIS - APPLICATION

9.1 Clinical Testing
  9.1.1 Overview
  9.1.2 Clinical Testing: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9.2 Veterinary Diagnostics
  9.2.1 Overview
  9.2.2 Veterinary Diagnostics: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9.3 Food Safety & Environment Testing
  9.3.1 Overview
  9.3.2 Food Safety & Environment Testing: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Drug Development & Quality Testing
  9.4.1 Overview
  9.4.2 Drug Development & Quality Testing: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

10. EUROPE LATERAL FLOW ASSAY MARKET ANALYSIS - END USER

10.1 Hospitals and Clinics
  10.1.1 Overview
  10.1.2 Hospitals and Clinics: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.2 Diagnostics Laboratories
  10.2.1 Overview
  10.2.2 Diagnostics Laboratories: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.3 Homecare
  10.3.1 Overview
  10.3.2 Homecare: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.4 Veterinary Clinics
  10.4.1 Overview
  10.4.2 Veterinary Clinics: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.5 Pharmaceutical & Biotechnology Companies
  10.5.1 Overview
  10.5.2 Pharmaceutical & Biotechnology Companies: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.6 Others
  10.6.1 Overview
  10.6.2 Others: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

11. EUROPE LATERAL FLOW ASSAY MARKET - COUNTRY ANALYSIS

11.1 Europe Lateral Flow Assay Market, Revenue and Forecast to 2030
  11.1.1 Europe Lateral Flow Assay Market Revenue and Forecasts and Analysis - By Country
    11.1.1.1 Germany: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.1.1 Overview
      11.1.1.1.2 Germany Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.1.3 Germany Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      11.1.1.1.4 Germany Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      11.1.1.1.5 Germany Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      11.1.1.1.6 Germany Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      11.1.1.1.7 Germany Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    11.1.1.2 UK: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.2.1 Overview
      11.1.1.2.2 UK Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.2.3 UK Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      11.1.1.2.4 UK Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      11.1.1.2.5 UK Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      11.1.1.2.6 UK Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      11.1.1.2.7 UK Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    11.1.1.3 France: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.3.1 Overview
      11.1.1.3.2 France Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.3.3 France Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      11.1.1.3.4 France Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      11.1.1.3.5 France Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      11.1.1.3.6 France Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      11.1.1.3.7 France Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    11.1.1.4 Italy: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.4.1 Overview
      11.1.1.4.2 Italy Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.4.3 Italy Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      11.1.1.4.4 Italy Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      11.1.1.4.5 Italy Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      11.1.1.4.6 Italy Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      11.1.1.4.7 Italy Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    11.1.1.5 Spain: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.5.1 Overview
      11.1.1.5.2 Spain Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.5.3 Spain Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      11.1.1.5.4 Spain Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      11.1.1.5.5 Spain Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      11.1.1.5.6 Spain Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      11.1.1.5.7 Spain Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    11.1.1.6 Benelux: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.6.1 Overview
      11.1.1.6.2 Benelux Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.6.3 Benelux Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      11.1.1.6.4 Benelux Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      11.1.1.6.5 Benelux Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      11.1.1.6.6 Benelux Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      11.1.1.6.7 Benelux Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    11.1.1.7 Rest of Europe: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.7.1 Overview
      11.1.1.7.2 Rest of Europe Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      11.1.1.7.3 Rest of Europe Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      11.1.1.7.4 Rest of Europe Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      11.1.1.7.5 Rest of Europe Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      11.1.1.7.6 Rest of Europe Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      11.1.1.7.7 Rest of Europe Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)

12. INDUSTRY LANDSCAPE

12.1 Overview
12.2 Growth Strategies in the Lateral Flow Assay Market
12.3 Organic Growth Strategies
  12.3.1 Overview
12.4 Inorganic Growth Strategies
  12.4.1 Overview

13. COMPANY PROFILES

13.1 F. Hoffmann-La Roche Ltd
  13.1.1 Key Facts
  13.1.2 Business Description
  13.1.3 Products and Services
  13.1.4 Financial Overview
  13.1.5 SWOT Analysis
  13.1.6 Key Developments
13.2 Siemens Healthineers AG
  13.2.1 Key Facts
  13.2.2 Business Description
  13.2.3 Products and Services
  13.2.4 Financial Overview
  13.2.5 SWOT Analysis
  13.2.6 Key Developments
13.3 Becton Dickinson and Co
  13.3.1 Key Facts
  13.3.2 Business Description
  13.3.3 Products and Services
  13.3.4 Financial Overview
  13.3.5 SWOT Analysis
  13.3.6 Key Developments
13.4 PerkinElmer Inc
  13.4.1 Key Facts
  13.4.2 Business Description
  13.4.3 Products and Services
  13.4.4 Financial Overview
  13.4.5 SWOT Analysis
  13.4.6 Key Developments
13.5 Hologic Inc
  13.5.1 Key Facts
  13.5.2 Business Description
  13.5.3 Products and Services
  13.5.4 Financial Overview
  13.5.5 SWOT Analysis
  13.5.6 Key Developments
13.6 QIAGEN NV
  13.6.1 Key Facts
  13.6.2 Business Description
  13.6.3 Products and Services
  13.6.4 Financial Overview
  13.6.5 SWOT Analysis
  13.6.6 Key Developments
13.7 bioMerieux SA
  13.7.1 Key Facts
  13.7.2 Business Description
  13.7.3 Products and Services
  13.7.4 Financial Overview
  13.7.5 SWOT Analysis
  13.7.6 Key Developments
13.8 QuidelOrtho Corp
  13.8.1 Key Facts
  13.8.2 Business Description
  13.8.3 Products and Services
  13.8.4 Financial Overview
  13.8.5 SWOT Analysis
  13.8.6 Key Developments
13.9 Abbott Laboratories
  13.9.1 Key Facts
  13.9.2 Business Description
  13.9.3 Products and Services
  13.9.4 Financial Overview
  13.9.5 SWOT Analysis
  13.9.6 Key Developments
13.10 Merck KGaA
  13.10.1 Key Facts
  13.10.2 Business Description
  13.10.3 Products and Services
  13.10.4 Financial Overview
  13.10.5 SWOT Analysis
  13.10.6 Key Developments
13.11 Bio-Rad Laboratories Inc
  13.11.1 Key Facts
  13.11.2 Business Description
  13.11.3 Products and Services
  13.11.4 Financial Overview
  13.11.5 SWOT Analysis
  13.11.6 Key Developments
13.12 Thermo Fisher Scientific Inc
  13.12.1 Key Facts
  13.12.2 Business Description
  13.12.3 Products and Services
  13.12.4 Financial Overview
  13.12.5 SWOT Analysis
  13.12.6 Key Developments

14. APPENDIX

14.1 About The Insight Partners
14.2 Glossary of Terms


More Publications